Generation of germ cells from pluripotent stem cells in mammals
Oper Res 71(4):12981317 Leao AA, Toledo FM, Oliveira JF, Carravilla MA, Alvarez-Valds R (2020) Irregular packing problems: a review of mathematical models
Regulatory Status and Safety Takeaway FDA Status: IGF-1 LR3 is not approved by the FDA for human therapeutic use and is highly restricted
A theoretically sound approach based on known mechanisms would combine KPV for NF-kB suppression, thymosin alpha-1 for immune regulation, BPC-157 or GHK-Cu for tissue repair, and collagen peptides for structural support
Thanks for replying & sharing this about your injection frequency - you've definitely convinced me to try weekly injections for a while to see if this makes a difference
BioMedicine, 11 (2), 5-10